GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Capex-to-Revenue

Iran Daru (XTEH:IRDR1) Capex-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Iran Daru's Capital Expenditure for the six months ended in . 20 was IRR0.00 Mil. Its Revenue for the six months ended in . 20 was IRR0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


Iran Daru Capex-to-Revenue Historical Data

The historical data trend for Iran Daru's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Capex-to-Revenue Chart

Iran Daru Annual Data
Trend
Capex-to-Revenue

Iran Daru Semi-Annual Data
Capex-to-Revenue

Competitive Comparison of Iran Daru's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Iran Daru's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Iran Daru's Capex-to-Revenue falls into.



Iran Daru Capex-to-Revenue Calculation

Iran Daru's Capex-to-Revenue for the fiscal year that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

Iran Daru's Capex-to-Revenue for the quarter that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Iran Daru  (XTEH:IRDR1) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Iran Daru Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Iran Daru's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Iran Daru (XTEH:IRDR1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines